CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOW FROM OPERATING ACTIVITIES
Net loss	$ (2,922,063)	$ (2,476,453)
Adjustments to reconcile net loss to net cash used in operating activities
Amortization	120,469	120,469
Stock options and warrants	327,118	635,603
(Increase) decrease in assets
Prepaid drug product for testing	(45,199)	46,699
Other current assets	(130,064)	(7,138)
Increase (decrease) in liabilities
Accounts payable and accrued expenses	(11,740)	(155,491)
Net cash used in operating activities	(2,661,479)	(1,836,311)
CASH FLOW FROM INVESTING ACTIVITIES
Purchase of fixed assets	(66,124)	0
Net cash used in investing activities	(66,124)	0
CASH FLOW FROM FINANCING ACTIVITIES
Net proceeds from sale of common stock	13,812,373	5,403,106
Net cash from financing activities	13,812,373	5,403,106
NET INCREASE (DECREASE) IN CASH	11,084,770	3,566,795
Cash, beginning of period	3,551,832	534,046
Cash, end of period	14,636,602	4,100,841
Cash paid for
Interest	0	0
Income taxes	0	0
Placement Agent
Non-cash financing activities
Common stock issued	$ 0	$ 448,950